1. Home
  2. PROV vs ARMP Comparison

PROV vs ARMP Comparison

Compare PROV & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROV
  • ARMP
  • Stock Information
  • Founded
  • PROV 1956
  • ARMP N/A
  • Country
  • PROV United States
  • ARMP United States
  • Employees
  • PROV N/A
  • ARMP 75
  • Industry
  • PROV Savings Institutions
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PROV Finance
  • ARMP Health Care
  • Exchange
  • PROV Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • PROV 102.0M
  • ARMP 104.3M
  • IPO Year
  • PROV 1996
  • ARMP N/A
  • Fundamental
  • Price
  • PROV $15.56
  • ARMP $2.93
  • Analyst Decision
  • PROV Hold
  • ARMP Strong Buy
  • Analyst Count
  • PROV 1
  • ARMP 1
  • Target Price
  • PROV $16.50
  • ARMP $9.00
  • AVG Volume (30 Days)
  • PROV 5.9K
  • ARMP 11.9K
  • Earning Date
  • PROV 10-27-2025
  • ARMP 11-12-2025
  • Dividend Yield
  • PROV 3.60%
  • ARMP N/A
  • EPS Growth
  • PROV N/A
  • ARMP N/A
  • EPS
  • PROV 0.93
  • ARMP N/A
  • Revenue
  • PROV $39,666,000.00
  • ARMP $6,868,000.00
  • Revenue This Year
  • PROV $7.74
  • ARMP $8.43
  • Revenue Next Year
  • PROV $4.06
  • ARMP N/A
  • P/E Ratio
  • PROV $16.73
  • ARMP N/A
  • Revenue Growth
  • PROV 1.90
  • ARMP 84.67
  • 52 Week Low
  • PROV $12.98
  • ARMP $0.90
  • 52 Week High
  • PROV $16.70
  • ARMP $3.14
  • Technical
  • Relative Strength Index (RSI)
  • PROV 55.41
  • ARMP 59.33
  • Support Level
  • PROV $15.46
  • ARMP $2.79
  • Resistance Level
  • PROV $15.79
  • ARMP $3.02
  • Average True Range (ATR)
  • PROV 0.20
  • ARMP 0.15
  • MACD
  • PROV 0.01
  • ARMP 0.00
  • Stochastic Oscillator
  • PROV 43.48
  • ARMP 71.62

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: